Paper

Marine bromophenol bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, represses angiogenesis in HUVEC cells and in zebrafish embryos via inhibiting the VEGF signal systems.

Published Oct 1, 2015 · Xin Qi, Ge Liu, Lin Qiu

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro StudyRigorous Journal

Study Snapshot

BDDE, a marine bromophenol, shows antiangiogenesis capabilities in vitro and in zebrafish embryos, suggesting its potential as a cancer prevention and therapy drug candidate.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Marine bromophenol bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, represses angiogenesis in HUVEC cells and in zebrafish embryos via inhibiting the VEGF signal systems.

References

Citations